An FDA analysis shows the average manufacturer price (AMP) for generic drugs can be up to 54% lower than the brand drug price before competition when there are at least two generic competitors on the market. With six or more competitors, generic prices show a price reduction of more than 95% compared to brand prices, the agency says in a generic competition and drug prices report released Friday (Dec. 13). The generic drug lobby on Friday touted the report for...